Commonwealth Equity Services
PACB icon

Commonwealth Equity Services’s Pacific Biosciences PACB Stock Holding History

Commonwealth Equity Services’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-63,227
Closed -$78K – 4381
2025
Q2 		$78K Sell
63,227
-13,135
-17% -$15.2K ﹤0.01% 4101
2025
Q1 		$90K Sell
76,362
-35
-0% -$54 ﹤0.01% 4007
2024
Q4 		$140K Sell
76,397
-14,924
-16% -$29.1K ﹤0.01% 3848
2024
Q3 		$155K Buy
91,321
+78,531
+614% +$129K ﹤0.01% 3785
2024
Q2 		$18K Sell
12,790
-1,080
-8% -$2.18K ﹤0.01% 3977
2024
Q1 		$52K Sell
13,870
-1,589
-10% -$9.3K ﹤0.01% 3886
2023
Q4 		$152K Sell
15,459
-454
-3% -$3.71K ﹤0.01% 3598
2023
Q3 		$133K Sell
15,913
-667
-4% -$7.62K ﹤0.01% 3510
2023
Q2 		$221K Hold
16,580
– – ﹤0.01% 3317
2023
Q1 		$192K Sell
16,580
-185
-1% -$1.84K ﹤0.01% 3332
2022
Q4 		$137K Sell
16,765
-19,203
-53% -$165K ﹤0.01% 3349
2022
Q3 		$208K Sell
35,968
-6,040
-14% -$34.7K ﹤0.01% 3136
2022
Q2 		$185K Sell
42,008
-5,828
-12% -$35.4K ﹤0.01% 3228
2022
Q1 		$435K Sell
47,836
-2,105
-4% -$24.2K ﹤0.01% 2635
2021
Q4 		$1.02M Buy
49,941
+29,338
+142% +$708K ﹤0.01% 1971
2021
Q3 		$526K Buy
20,603
+3,721
+22% +$110K ﹤0.01% 2434
2021
Q2 		$590K Buy
16,882
+788
+5% +$22.9K ﹤0.01% 2342
2021
Q1 		$536K Buy
16,094
+5,526
+52% +$193K ﹤0.01% 2278
2020
Q4 		$274K Buy
+10,568
New +$180K ﹤0.01% 2657

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return

Commonwealth Equity Services's PACB Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Pacific Biosciences (PACB) in Q3 2025, closing a stake of 63,227 shares — an estimated $78K sold.

Commonwealth Equity Services first reported a position in PACB in Q4 2020 and held it in 19 quarters. The position peaked at $1.02M in Q4 2021. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Pacific Biosciences position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 63,227 Pacific Biosciences shares in Q3 2025, an estimated $78K.
  • Commonwealth Equity Services first reported a position in Pacific Biosciences in Q4 2020 and held it in 19 quarters.
  • Commonwealth Equity Services's Pacific Biosciences position peaked at $1.02M in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.